Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | BMP1 | P13497 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3433506 | 0.86 | LPAR1 (0.35) | L3MBTL1PPARD | |
| SCHEMBL18628115 | 0.78 | LPAR1 (0.37) | L3MBTL1PPARGPPARDPPARAMAPT | |
| SCHEMBL3433166 | 0.77 | LPAR1 (0.31) | — | |
| SCHEMBL3434668 | 0.73 | LPAR1 (0.37) | L3MBTL1PPARD | |
| SCHEMBL9356167 | 0.72 | P2RY6 (0.44) | P2RY6TSHRMEN1KMT2ATDP1 | |
| SCHEMBL890271 | 0.68 | HSD17B10 (0.34) | KEAP1NFE2L2P2RY6 | |
| SCHEMBL4598913 | 0.68 | P2RY6 (0.50) | P2RY6PPARGPPARAMEN1KMT2A | |
| SCHEMBL862173 | 0.67 | PPARG (0.35) | KEAP1NFE2L2ALDH1A1KDM4ETSHR | |
| SCHEMBL8548578 | 0.64 | CTSA (0.45) | ALDH1A1KDM4EMEN1KMT2ACYP1A2 | |
| SCHEMBL480490 | 0.63 | P2RY6 (0.39) | P2RY6PPARGPPARDPPARATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8216856-B2 | Luminescent lanthanide labelling reagents and their use | ABACUS DIAGNOSTICA OY (FI) | 2012-07-10 | — | — | US | disclosed |
| EP-2052252-B1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | ABACUS DIAGNOSTICA OY (FI) | 2010-11-10 | — | — | EP | disclosed |
| US-20100081211-A1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | ABACUS DIAGNOSTICA OY (FI) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081211-A1 | LUMINESCENT LANTHANIDE LABELLING REAGENTS AND THEIR USE | SCLY, SRM, TST | L3MBTL1 60/4885KEAP1 3856/4885NFE2L2 3434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.